pyridinolcarbamate has been researched along with Glomerulonephritis in 1 studies
Pyridinolcarbamate: A drug that has been given by mouth in the treatment of atherosclerosis and other vascular disorders, hyperlipidemias, and thrombo-embolic disorders. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1408)
Glomerulonephritis: Inflammation of the renal glomeruli (KIDNEY GLOMERULUS) that can be classified by the type of glomerular injuries including antibody deposition, complement activation, cellular proliferation, and glomerulosclerosis. These structural and functional abnormalities usually lead to HEMATURIA; PROTEINURIA; HYPERTENSION; and RENAL INSUFFICIENCY.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lagrue, G | 1 |
| Hirbec, G | 1 |
| Moisy, M | 1 |
| Sternberg, M | 1 |
| Blanc, C | 1 |
1 other study available for pyridinolcarbamate and Glomerulonephritis
| Article | Year |
|---|---|
[Action of pyridinol carbamate on hetero-immune Masugi nephritis in the rat (author's transl)].
Topics: Animals; Capillary Permeability; Carbamates; Disease Models, Animal; Glomerulonephritis; Immune Sera | 1976 |